The quest for an HIV-1 vaccine: will mRNA deliver us from evil?

Expert Rev Vaccines. 2023 Jan-Dec;22(1):267-269. doi: 10.1080/14760584.2023.2184803.

Author

Affiliation

¹ Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.

PMID: 36825464
DOI: 10.1080/14760584.2023.2184803

No abstract available

Keywords: HIV-1; Heterologous tier-2 challenge; Neutralizing antibodies; Primate models; Protection; Vaccine; Virus-like particles; mRNA.

Publication types

Editorial
Research Support, N.I.H., Intramural

MeSH terms

AIDS Vaccines*
HIV Infections* / prevention & control
HIV-1* / genetics
Humans
RNA, Messenger

Substances

AIDS Vaccines
RNA, Messenger